---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-24-000076"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T14:08:42.881906+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Q2 revenue $338M (+5.6%), GAAP EPS $0.61 (+75.7%), raises FY guidance

## Summary
- Revenue $338.0M, up 5.6% YoY; constant currency revenue up 6.6%.
- GAAP EPS $0.61, up 75.7%; Non-GAAP EPS $0.92, up 16.8%.
- GAAP operating margin 13.6% vs 9.0%; Non-GAAP operating margin 20.1% vs 19.1%.
- Raised full-year 2024 revenue and EPS guidance.
- WRAPSODY WAVE study 6-month outcomes to be presented at CIRSE Sept 14-16; FDA PMA under review.

## SEC filing metadata
- accession: 0000856982-24-000076
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698224000076/0000856982-24-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698224000076/mmsi-20240801x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-24-000076
- JSON: https://secwatch.observer/filing/0000856982-24-000076.json
- Plain text: https://secwatch.observer/filing/0000856982-24-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.